SAVE THE DATE: 19 May 2010-Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicinesSubmitted by thiru on 18. May 2010 - 11:05
Moving beyond the EWG: Charting a new path for WHO to promote innovation AND access to medicines
Non-governmental organization perspectives on de-linkage, prizes and the R+D Treaty
Date: Wednesday, 19 May 2010
Location: Salle XXV, Palais des Nations
Time: 13:00 to 14:30
Wednesday, 07 January 2009
Program and Agenda
Roundtable on De-linking R&D Incentives from Prices
Designing Innovation Inducement Prizes for Diagnostics, New Drugs and Vaccines for Type II and III diseases and conditions, with a particular focus on TB and Chagas Disease
Friday, 09 November 2007
KEI comments to IGWG2
8 November 2007
KEI appreciates the opportunity to speak today. Our comments will focus on 3 items.
Wednesday, 23 May 2007
Informe de KEI
This morning the 62nd session World Health Assembly agreed to a resolution on public health, innovation and intellectual property that, among other things, settled outstanding issues regarding the “stakeholders” for various parts of the Global Strategy and Plan of Action. (GS/PoA). With regard to the issue of a possible medical R&D treaty, the outcome of the negotiation was something of a split decision. On the one hand, the WHA agreed that the WHO would not be a stakeholder, in terms of the specific element of the WHO Global Strategy document.
This is the statement that the government of Bolivia delivered today to the 62nd World Health Assembly at the conclusion of the discussions on the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (WHA 61.21).
Statement of Bolivia on resolving outstanding elements of agenda item 12.8
Joint Statement on behalf of
Bangladesh, Barbados, Bolivia and Suriname, and
Cuba, Ecuador, Nicaragua and Venezuela
21 May 2009
Today at the World Health Assembly (WHA) the US and EU are opposing that the WHO have a mandate on global research and development norms, including the possibility for Member States to negotiate at WHO a global biomedical R&D treaty.
Developing countries governments made very strong interventions this morning on this issue (among them India, Bolivia, Barbados, Suriname, Bangladesh, Ghana, Argentina, Venezuela, Nicaragua, Ecuador, Cuba and Jamaica) and are wondering where are the promises of multilateralism made by the new Obama administration.
Thursday, 21 May 2009
Delegates at the World Health Assembly will have to grapple with how best to deploy their delegations to simultaneously cover pandemic influenza and resolving the outstanding elements of the WHO IGWG Plan of Action.
Today’s WHO Journal lists the following morning schedule for Committee A.
Item 11 (continued) Medium-strategic plan, including Proposed Programme budget 2010-2011
To consider appropriation resolution for financial period 2010-2011
Item 12 (continued) Technical and health matters